"Paxlovid is not a drug that gets you better faster. It's not a drug that decreases long COVID," Adalja said. "It's a drug that prevents you from being hospitalized or dying." ...

Paxlovid, an antiviral therapy that is prescribed to COVID-19 patients to prevent severe illness, soon will cost more than double the $529 that the federal government had paid for the treatment.

Sean Marchese, a registered nurse at The Mesothelioma Center in Florida, reveals who should, and shouldn't, take Paxlovid after a COVID-19 diagnosis.

Paxlovid, available since December 2021, reduced the COVID-19 death rate in high-risk patients by 73%, according to a study National Institutes of Health researchers released last year. Yet uptake ...

Paxlovid has been shown to reduce the risk of severe COVID in high-risk patients, but those who could most benefit from the drug aren't getting it.

Pfizer, Paxlovid’s manufacturer, found in its own study of the drug that rebound occurs in about 1.7% of Paxlovid patients, which is slightly lower than what they found in the untreated, ...

Pfizer’s antiviral COVID-19 treatment Paxlovid is safe and effective at treating adults with mild to moderate COVID-19 who are at high risk of progressing to severe disease, including hospita… ...

A U.S. Food and Drug Administration analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid and illness rebound, the FDA said in a new report.. Rebound rates are ...

Though Paxlovid has been proven effective in reducing hospitalizations and deaths in high-risk Covid patients, some people have become wary of the medication because a small percentage of patients ...

Dr. Agus on what's driving COVID rebound cases after Paxlovid 04:45. Taking Pfizer's blockbuster COVID-19 pills, Paxlovid, at the same time as a rival's treatment for the virus might be safe and ...

Everyone 65 and older should take Paxlovid unless they have a specific reason for why they cannot do so (for example, if they are taking another medication that would interact poorly with it). And ...